MetaADEDB 2.0 @ LMMD
Elephantiasis Nostras Verrucosa
(UMLS:C0544766)
UMLS ID:
C0544766
MeSH ID:
D004604
Classification:
Name:
Hemic and Lymphatic Diseases
MeSH Tree Number(s):
C15.604.496.320
Synonym(s)
1.
Elephantiasis Nostras Verrucosa
2.
Elephantiasis nostras verrucosa
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1LenalidomideFAERS: 1US FAERS
Similar ADE(s)
NameSemantic Similarity
1Adenitis31%
2Histiocytosis31%
3Lymphadenitis31%
4Lymphangitis31%
5Splenic Diseases31%
6Thymus Hyperplasia31%
7Pseudolymphoma31%
8Lymphadenopathy31%
9Lymphocele20.9%
10Lymphoproliferative Disorders20.9%
11Lymphatic Abnormalities20.9%
12Thymus Neoplasms20.5%
13Hypersplenism20%
14Lymphangiectasis, Intestinal20%
15Sarcoidosis20%
16Mucocutaneous Lymph Node Syndrome15.3%
17Lymphohistiocytosis, Hemophagocytic14.8%
18Erdheim-Chester Disease14.8%
19Granuloma13.6%
20Histiocytic Disorders, Malignant13.6%
21Splenic Infarction13.6%
22Splenic Neoplasms13.6%
23Agammaglobulinemia13.6%
24Histiocytosis, Langerhans-Cell13.3%
25Tumor Lysis Syndrome13.3%
26Heavy Chain Disease12.4%
27Infectious Mononucleosis10.6%
28Anemia10.3%
29Blood Coagulation Disorders10.3%
30Blood Platelet Disorders10.3%
31Bone Marrow Diseases10.3%
32Hemorrhagic Disorders10.3%
33Leukocyte Disorders10.3%
34Methemoglobinemia10.3%
35Pancytopenia10.3%
36Polycythemia10.3%
37Splenic Rupture10.3%
38Sulfhemoglobinemia10.3%
39Thrombophilia10.3%
40Erythrocytosis10.3%
41Lymphoma10.2%
42Disseminated Intravascular Coagulation10%
43Protein S Deficiency10%
44Thymoma9.9%
45Sezary Syndrome9.9%
46Malignant histiocytosis9.9%
47Sarcoidosis, Pulmonary9.9%
48Histiocytic sarcoma9.9%
49Thrombocythemia, Essential8.9%
50Waldenstrom Macroglobulinemia8.5%
51Autoimmune Lymphoproliferative Syndrome8.2%
52Thrombocytosis7.7%
53Splenosis7.4%
54Hodgkin Disease7.4%
55Lymphoma, Non-Hodgkin7.4%
56Leukemia, T-Cell7.3%
57Transfusion Reaction7.3%
58Leukemia, B-Cell7.3%
59Hypotensive Transfusion Reaction7.3%
60Thrombasthenia7.3%
61Antithrombin III Deficiency7.3%
62Protein C Deficiency7.3%
63Pregnancy Complications, Hematologic7%
64Hematologic Neoplasms7%
65Anemia, Hemolytic6.7%
66Anemia, Macrocytic6.7%
67Eosinophilia6.7%
68Hypoproteinemia6.7%
69Leukopenia6.7%
70Thrombocytopenia6.7%
71Leukostasis6.7%
72Bone Marrow Neoplasms6.7%
73MYELODYSPLASTIC SYNDROME6.7%
74Eosinophilic Granuloma6.6%
75Vitamin K Deficiency6.6%
76Afibrinogenemia6.6%
77Factor VII Deficiency6.6%
78Factor X Deficiency6.6%
79Factor XII Deficiency6.6%
80Hemophilia A6.6%
81Activated Protein C Resistance6.6%
82Factor II deficiency6.6%
83Factor VIII Deficiency6.6%
84Factor V deficiency6.6%
85Factor XI Deficiency6.6%
86Hypoprothrombinemias6.6%
87Hemoglobinuria, Paroxysmal6.5%
88Leukemoid Reaction6.5%
89Lymphoma, Follicular6%
90T-Cell Lymphoma6%
91Mantle cell lymphoma6%
92Precursor B-Cell Lymphoblastic Leukemia-Lymphoma6%
93Leukemia, Large Granular Lymphocytic6%
94Precursor T-Cell Lymphoblastic Leukemia-Lymphoma6%
95Composite Lymphoma5.9%
96Polycythemia Vera5.8%
97Lymphangioleiomyomatosis5.8%
98Lymphoma, T-Cell, Cutaneous5.4%
99Lymphoma, AIDS-Related5.4%
100Enteropathy-Associated T-Cell Lymphoma5.4%
101Primary Effusion Lymphoma5.4%
102Anemia, Diamond-Blackfan5.2%
103Mycosis Fungoides5.1%
104Lymphomatoid Papulosis5.1%
105Plasmablastic lymphoma5.1%
106Primary Myelofibrosis4.9%
107Agranulocytosis4.9%
108Anemia, Megaloblastic4.9%
109Lymphocytosis4.9%
110Myelofibrosis4.9%
111Myeloid Metaplasia4.9%
112Hypoalbuminemia4.9%
113Hypereosinophilic syndrome4.9%
114bone marrow fibrosis4.9%
115Thrombotic Microangiopathies4.9%
116Purpura, Thrombotic Thrombocytopenic4.7%
117Anemia, Neonatal4.5%
118Leukocytosis4.5%
119Paraproteinemias4.5%
120Pelger-Huet Anomaly4.5%
121Pleocytosis4.5%
122Wiskott-Aldrich Syndrome4.5%
123Lymphomatoid Granulomatosis4.4%
124Anemia, Sickle Cell4.3%
125Thalassemia4.3%
126Neutropenia4.1%
127Cryoglobulinemia3.9%
128Monoclonal Gammopathy of Undetermined Significance3.9%
129Febrile Neutropenia3.6%
130Burkitt Lymphoma3.6%
131Autoimmune thrombocytopenia3.6%
132Immune thrombocytopenic purpura3.6%
133Hemolytic-Uremic Syndrome3.5%
134Hypergammaglobulinemia3.4%
135Sickle Cell Trait3.4%
136Lymphopenia3.4%
137Transfusion-Related Acute Lung Injury3.4%
138Ecchymosis3.3%
139Petechiae3.3%
140Purpura3.3%
141Job Syndrome3.3%
142Fanconi Anemia3.3%
143Leukemia, Myelomonocytic, Chronic3.3%
144Purpura, Hyperglobulinemic3.3%
145Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative3.3%
146Thrombocytopenic purpura3.1%
147Atypical Hemolytic Uremic Syndrome3%
148Multiple Myeloma2.8%
149Pulmonary Eosinophilia2.8%
150Eosinophilic Pneumonia2.8%
151Leukemia, Myeloid, Chronic-Phase2.7%
152Hydrops Fetalis2.7%
153Anemia, Pernicious2.7%
154Eosinophilia-Myalgia Syndrome2.5%
155Acute Chest Syndrome2.5%
156Chronic granulomatous disease2.5%
157Shwartzman Phenomenon2.5%
158Hemangioma, Cavernous2.5%
159Scurvy2.4%
160Purpura Fulminans2.4%
161Waterhouse-Friderichsen Syndrome2.3%
162Niemann-Pick Disease, Type C2.2%
163POEMS Syndrome2%
164Kernicterus1.9%
165Pseudoxanthoma Elasticum1.3%
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.